For instance, in February 2024, the Ministry of Health, Canada, introduced Bill C-64 to establish universal pharmacare, covering diabetes drug such as insulin USD 900-USD 1,700/year, metformin ~USD 100/year, and adjunct therapies USD 100-USD 1,000+/year for type 1 and type 2 diabetes patients under single-payer insurance
A prespecified analysis of SELECT further suggested reductions in composite HF outcomes among participants with and without prior HF, although these findings were secondary analyses rather than HF-dedicated trial endpoints [17]
74, 140, 143, 144, 145, 146, 147, 148 In some models, also non-ketogenic low-CHO diets (1015E% CHO) led to significant tumor growth retardation that was correlated to low blood glucose and insulin levels
Look for products that meet UK regulatory standards with compliant labelling (including UK business details and batch/lot numbers)